These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29523327)

  • 1. Investigating the inhibitory potential of 2-Aminopurine metal complexes against serine/threonine protein kinases from Mycobacterium tuberculosis.
    Bais VS; Mohapatra B; Ahamad N; Boggaram S; Verma S; Prakash B
    Tuberculosis (Edinb); 2018 Jan; 108():47-55. PubMed ID: 29523327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.
    Chen D; Ma S; He L; Yuan P; She Z; Lu Y
    Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis.
    Mori M; Sammartino JC; Costantino L; Gelain A; Meneghetti F; Villa S; Chiarelli LR
    Curr Top Med Chem; 2019; 19(9):646-661. PubMed ID: 30827246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
    Székely R; Wáczek F; Szabadkai I; Németh G; Hegymegi-Barakonyi B; Eros D; Szokol B; Pató J; Hafenbradl D; Satchell J; Saint-Joanis B; Cole ST; Orfi L; Klebl BM; Kéri G
    Immunol Lett; 2008 Mar; 116(2):225-31. PubMed ID: 18258308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.
    Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
    Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ser/Thr protein kinase PknB is essential for sustaining mycobacterial growth.
    Fernandez P; Saint-Joanis B; Barilone N; Jackson M; Gicquel B; Cole ST; Alzari PM
    J Bacteriol; 2006 Nov; 188(22):7778-84. PubMed ID: 16980473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity.
    Xu J; Wang JX; Zhou JM; Xu CL; Huang B; Xing Y; Wang B; Luo R; Wang YC; You XF; Lu Y; Yu LY
    Sci Rep; 2017 Jul; 7(1):5093. PubMed ID: 28698545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the messengers: Serine/threonine protein kinases as potential targets for antimycobacterial drug development.
    Khan MZ; Kaur P; Nandicoori VK
    IUBMB Life; 2018 Sep; 70(9):889-904. PubMed ID: 29934969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation.
    Singh N; Tiwari S; Srivastava KK; Siddiqi MI
    J Chem Inf Model; 2015 Jun; 55(6):1120-9. PubMed ID: 25965448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the structural requirements of aminopyrimidine derivatives for good potency against both purified enzyme and whole cells of M. tuberculosis: combination of HQSAR, CoMSIA, and MD simulation studies.
    Punkvang A; Hannongbua S; Saparpakorn P; Pungpo P
    J Biomol Struct Dyn; 2016 May; 34(5):1079-91. PubMed ID: 26156406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinases PknA and PknB independently and coordinately regulate essential Mycobacterium tuberculosis physiologies and antimicrobial susceptibility.
    Zeng J; Platig J; Cheng TY; Ahmed S; Skaf Y; Potluri LP; Schwartz D; Steen H; Moody DB; Husson RN
    PLoS Pathog; 2020 Apr; 16(4):e1008452. PubMed ID: 32255801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth.
    Wlodarchak N; Teachout N; Beczkiewicz J; Procknow R; Schaenzer AJ; Satyshur K; Pavelka M; Zuercher W; Drewry D; Sauer JD; Striker R
    Mol Pharm; 2018 Nov; 15(11):5410-5426. PubMed ID: 30285456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors.
    Caballero J; Morales-Bayuelo A; Navarro-Retamal C
    J Comput Aided Mol Des; 2018 Dec; 32(12):1315-1336. PubMed ID: 30367309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis Ser/Thr protein kinase B mediates an oxygen-dependent replication switch.
    Ortega C; Liao R; Anderson LN; Rustad T; Ollodart AR; Wright AT; Sherman DR; Grundner C
    PLoS Biol; 2014 Jan; 12(1):e1001746. PubMed ID: 24409094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and biochemical analysis of the serine/threonine protein kinases PknA, PknB, PknG and PknL of Corynebacterium glutamicum: evidence for non-essentiality and for phosphorylation of OdhI and FtsZ by multiple kinases.
    Schultz C; Niebisch A; Schwaiger A; Viets U; Metzger S; Bramkamp M; Bott M
    Mol Microbiol; 2009 Nov; 74(3):724-41. PubMed ID: 19788543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents.
    Lougheed KE; Osborne SA; Saxty B; Whalley D; Chapman T; Bouloc N; Chugh J; Nott TJ; Patel D; Spivey VL; Kettleborough CA; Bryans JS; Taylor DL; Smerdon SJ; Buxton RS
    Tuberculosis (Edinb); 2011 Jul; 91(4):277-86. PubMed ID: 21482481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.